BioLargo Year-End 2023 Earnings Results Webcast and Conference Call on Tuesday, April 2, 2024 – 5:00 PM Eastern Time
WESTMINSTER, CA / ACCESSWIRE / April 1, 2024 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Tuesday, April …
WESTMINSTER, CA / ACCESSWIRE / April 1, 2024 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Tuesday, April 2, 2024, at 2:00 pm Pacific / 5:00 pm Eastern. Open to the public, the webcast will be held to review the company's financial results for the year ending December 31, 2023, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: | |
Teleconference Domestic: |
877-545-0523 |
Teleconference International: Participant Access Code: |
973-528-0016 614240 |
To watch or listen to a replay of the webcast or teleconference:
Webcast Replay Expiration: |
Tuesday, July 02, 2024 |
Teleconference Replay Expiration: |
Tuesday, April 16, 2024 |
Teleconference Replay Domestic: |
877-481-4010 |
Teleconference Replay International: |
919-882-2331 |
Replay Passcode: |
50271 |
The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
Lesen Sie auch
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and
wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent
or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.